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T

he ubiquitous clathrin heavy chain (CHC), the main
component of clathrin-coated vesicles, is well characterized for its role in intracellular membrane traffic and endocytosis from the plasma membrane (PM).
Here, we demonstrate that in skeletal muscle CHC regulates the formation and maintenance of PM–sarcomere
attachment sites also known as costameres. We show that
clathrin forms large coated lattices associated with actin
filaments and the muscle-specific isoform of -actinin at
the PM of differentiated myotubes. Depletion of CHC in

myotubes induced a loss of actin and -actinin sarcomeric
organization, whereas CHC depletion in vivo induced a
loss of contractile force due to the detachment of sarcomeres from the PM. Our results suggest that CHC contributes to the formation and maintenance of the contractile
apparatus through interactions with costameric proteins
and highlight an unconventional role for CHC in skeletal
muscle that may be relevant to pathophysiology of neuromuscular disorders.

Introduction
Clathrin is composed of trimerized heavy chains (CHCs) with
bound light chains (CLCs) and assembles to form a membrane
coat. The clathrin lattice formation on cellular membranes is
initiated by clathrin adaptors that are drawn into the lattice and
trigger clathrin-coated vesicle (CCV) budding at various subcellular compartments (Pearse and Robinson, 1990; Kirchhausen,
1999; Brodsky, 2012). Once the invagination process has initiated, dynamin family members associate with the neck of the
forming pit, recruit additional proteins including actin, and
allow the scission of the coated vesicle (Fujimoto et al., 2000;
Merrifield et al., 2002). The role of dynamin 2 (DNM2) in skeletal muscle has received considerable attention because the
F. Piétri-Rouxel and M. Bitoun contributed equally to this paper.

autosomal-dominant form of centronuclear myopathy (CNM)
has been linked to mutations in the DNM2 gene (Bitoun et al.,
2005). DNM2 is involved in various cellular processes, but to
date it remains unclear whether its role in CCV fission is implicated in centronuclear myopathy.
Several recent studies have proposed a role for clathrin
and dynamin in actin organization that is distinct from coated
vesicle formation (Schafer et al., 2002; Veiga et al., 2007;
Saffarian et al., 2009; Bonazzi et al., 2011, 2012). Intriguingly, a
role for clathrin in myofibril assembly was previously proposed
(Kaufman et al., 1990), and several teams have reported direct protein–protein interaction between CHC, -actinin, and
vinculin, two focal adhesion proteins crucial for muscle function (Schook et al., 1979; Burridge et al., 1980; Merisko, 1985;
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Merisko et al., 1988; Fausser et al., 1993). -Actinin and vinculin
are expressed in both skeletal and cardiac muscles, where they are
localized to a specialized compartment called the “costamere.”
Costameres, muscle-specific adhesion sites, are subsarcolemmal protein assemblies circumferentially aligned in
register with Z-disks of peripheral myofibrils. They were originally described as electron-dense plaques rich in the focal adhesion protein vinculin, and function as attachment complexes
(Pardo et al., 1983a,b; Shear and Bloch, 1985). They are located
between the plasma membrane and myofibrils and play both a
mechanical and a signaling role during contraction, transmitting force from the contractile apparatus to the ECM in order
to stabilize skeletal muscle fibers. They are considered as the
“Achilles’ Heel” of skeletal muscle because, when disrupted,
they directly contribute to the development of several distinct
myopathies (Blake et al., 2002; Ervasti, 2003). In the present
work, we have addressed the role played by CHC in skeletal
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muscle costamerogenesis and costamere maintenance. We
show that clathrin associates with -actinin at the surface of
myotubes and forms large plaques that are associated with actin
filaments. Depletion of CHC induces severe defects in -actinin
distribution and subsequently leads to defective costamere formation in vitro and induces impairment of contractile properties
associated with structural abnormalities including sarcomere
disorganization as well as detachment of the sarcomeres from
the sarcolemma in vivo.

Results
CHC is a component of the costameric
complex in skeletal muscle

In adult skeletal muscle, DNM2 and CHC are both localized
at the level of the I-band and present a striated pattern that overlaps with the muscle-specific -actinin (isoform 2) staining

Downloaded from jcb.rupress.org on June 3, 2014

Figure 1. CHC association with -actinin2 in adult skeletal muscle. (A) Confocal sections of mouse skeletal muscle were processed for double-immunofluorescent labeling of DNM2 (red) and -actinin (green) or CHC (red) and -actinin (green). Bars, 10 µm. (B) The fluorescence intensity as a function
of distance on the fiber was plotted for eight successive striations, and was reported on the graph for each labeling. The green curve corresponds to the
green immunolabeling, and the red curve corresponds to the red labeling. (C and D) CHC localization in mouse dissociated FDB fibers. (C) Confocal sections of fibers processed for immunofluorescent labeling with the monoclonal antibody against CHC (X22, green). Bars: (main panel) 10 µm; (inset) 2 µm.
(D) XZ and YZ projections of confocal optical sections illustrated in C. Bars, 10 µm. (E) Immunoblot of proteins associated with CHC, -actinin (isoform
2), vinculin, or control immunoprecipitates from mouse muscle lysates and 1–5% lysate input. Bands for coimmunoprecipitated CHC, -actinin (isoform 2),
vinculin, talin, or CLC are indicated at the right.
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Downloaded from jcb.rupress.org on June 3, 2014

Figure 2. CHC association with -actinin2 and actin at the PM of differentiated myotubes. (A) Localization of -actinin (green) and CHC (red) in mouse
primary myotubes differentiated for 4 d. Inset in Overlay panel is displayed on the right. (B) Immunoblot analysis of proteins associated with CHC or
control immunoprecipitates from subcellular fractions (plasma membrane, PM and cytosol, CYT) of 3T3 fibroblasts (FB), undifferentiated C2C12 (MB), and
differentiated C2C12 cells (MT). (C) Immunoblot analysis of proteins associated with -actinin or control immunoprecipitates from subcellular fractions (PM
and CYT) of 3T3 fibroblasts (FB), undifferentiated C2C12 (MB), and differentiated C2C12 cells (MT). (D) Confocal microscopy of AP2 (green) and CHC
(red) in differentiated C2C12 skeletal muscle cells. The left panel displays images from the top of the myotube and the right panel displays images from
the middle of the myotube. Arrows indicate large clusters of colocalization between AP2 and CHC and arrowheads indicate intracellular clusters near the
nuclei positive for CHC and negative for AP2. (E) XZ and YZ projections of serial confocal sections are shown on the overlay. Bar, 10 µm.

(Fig. 1, A and B; Kaufman et al., 1990; Butler et al., 1997;
Towler et al., 2004; Durieux et al., 2010; Cowling et al., 2011).
Using confocal optical sectioning and 3D reconstruction, we
demonstrated that this striated labeling was mainly present at
the surface of dissociated fibers (Fig. 1, C and D). Analysis of
the compartment labeled by anti-CHC antibodies on adult skeletal muscle using electron microscopy revealed that clathrin is
present along the sarcolemma and localizes at sites that correspond to contacts between sarcolemma and Z-discs, which are
also densely stained with tannic acid (Fig. S1, A and B). As
several studies have described a direct association between
-actinin and vinculin with clathrin (Schook et al., 1979; Burridge
et al., 1980; Merisko, 1985; Merisko et al., 1988; Fausser et al.,
1993), we then assessed the association between clathrin and
the -actinin–vinculin–talin complex in adult mouse skeletal
muscle (Fig. 1 E). We observed coimmunoprecipitation of CHC
and CLC upon -actinin immunoprecipitation, but only minor

amounts of vinculin and talin. Additionally, minor amounts of
-actinin are detected upon clathrin immunoprecipitation while
vinculin coimmunoprecipitates talin efficiently and some actinin, but not clathrin. This suggests that part of the -actinin
pool is associated with clathrin in a complex distinct from the
vinculin–talin–-actinin complex.
We further characterized the sites of interaction between
CHC and -actinin during the early steps of differentiation
in primary myotubes and showed that these proteins partially
colocalize along the plasma membrane (PM) after 4 d of differentiation (Fig. 2 A). By subcellular fractionation, we observed
an association between -actinin and CHC in the PM fraction
of fibroblasts, myoblasts, and differentiated myotubes. This
association was stronger in differentiated myotubes as the levels
of -actinin expression increase (Fig. 2, B and C). In addition,
we detected -actin in both CHC and -actinin immunoprecipitates from muscle cells. Several adaptor proteins are required
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for targeting clathrin to specific intracellular compartments and,
among these, AP2 is involved in recruiting clathrin to the PM.
In differentiated myotubes, AP2 was localized at the surface
of myotubes and displayed a predominant PM localization
(Fig. 2, D and E). These results show that clathrin is a costameric protein that is recruited by AP2 and associates with actin
and -actinin at the PM of differentiated myotubes.
Costameric clathrin forms large plaques
where -actinin and actin are localized

Myofibril assembly and subsequent sarcomere formation initiate at the PM. After the formation of a subcortical actin lattice,
additional nascent sarcomeres keep adding to the initial actin
network (Dlugosz et al., 1984; Epstein and Fischman, 1991;
Sanger et al., 2002; Quach and Rando, 2006). We hypothesized
that -actinin and actin rely on a clathrin scaffold at the PM to
start recruiting additional myofibrils and explored this possibility
using immunogold cytochemistry coupled with quick-freeze,
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deep-etch rotary replication and electron microscopy (Heuser,
1980). We showed that clathrin forms two distinct coated structures, i.e., large plaques that contain much more polymerized
clathrin that would be required to form a single vesicle (pseudocolored in red in Fig. 3, D and F) and coated vesicles found in
regions devoid of plaques (Fig. 3, D and F; and Fig. S1, C–G).
Using clathrin antibodies we were able to confirm that CHC
was indeed the proteinaceous material composing these structures (Fig. S1, C–K). As expected, -actinin strongly labeled
dense longitudinally organized actin filament bundles (Fig. 3 D,
arrows; and Fig. S2, A and B) that are reminiscent of the
contractile apparatus. In addition, -actinin was associated
with actin filaments that surround or overlap flat clathrin lattices (Fig. 3, E and G; and Fig. S2, A, C, and D) highly enriched with the adhesion marker 5 integrin (Fig. S2, E–H)
as previously described on rat myotubes (De Deyne et al., 1998;
Pumplin, 1989; Pumplin and Bloch, 1990), whereas vinculin was
not localized at these clathrin-coated plaques (unpublished data).

Downloaded from jcb.rupress.org on June 3, 2014

Figure 3. -Actinin and actin are localized on large flat clathrin-coated plaques. (A–C) Immunofluorescent staining of -actinin (A), CHC (B), and merged
images (C) in untreated differentiated primary mouse myotubes visualized using confocal microscopy. Bars, 5 µm. (D–G) Adherent plasmalemmal sheets
prepared from control primary myotubes differentiated for 4 d and labeled with -actinin antibodies followed by secondary antibodies conjugated to
18-nm colloidal gold particles. Gold particles are pseudocolored yellow (D–G) and clathrin lattices are pseudocolored pale red (D and F). The boxed
region in D and F is magnified in E and G, respectively. Note that -actinin is found on both actin cables (D, arrows) and branched filaments lying on top
of flat clathrin-coated lattices. Bars, 100 nm.

Published May 5, 2014

Our experiments on primary myotubes show that CHC forms
large plaques that may serve to anchor the actin cytoskeleton
and -actinin.
CHC is required for the formation
of costameres

We next tested the effect of CHC knockdown on -actinin subcellular organization. We achieved high knockdown efficiency in
C2C12 myotubes differentiated for 6 d (Fig. 4, A and B) with two
previously published siRNA sequences (Ezratty et al., 2009).
Additionally, we showed that levels of CLC were also reduced because of the instability of the light chain upon heavy chain depletion, as previously reported in nonmuscle cells (Brodsky, 1985;
Esk et al., 2010). Expression levels of -actinin, vinculin, and talin
were unaffected in myotubes treated with CHC siRNA (Fig. 4 A).

Downloaded from jcb.rupress.org on June 3, 2014

Figure 4. CHC regulates formation and organization of sarcomeres in cultured myotubes. (A) Differentiated C2C12 cells were
treated with control GAPDH siRNA, two different siRNA targeting CHC, a mixture of
both (CHC-1, CHC-2, CHC-1+2 indicated at
the top), and cell lysates immunoblotted for
proteins (indicated at the right). (B) CHC expression in cultured C2C12 myotubes treated
with GAPDH or CHC siRNA. The graph depicts quantification of CHC band intensity
(n = 8 for CHC-1 and n = 4 for CHC-2 and
CHC1+2; data are presented as mean ± SEM;
**, P < 0.01). (C) -Actinin staining in differentiated C2C12 skeletal muscle cells treated with
control GAPDH siRNA or CHC siRNA. DNA
staining (DAPI blue) identifies multinucleated
myotubes. The boxed region in the merged
images is magnified in the insets. Bars: (main
panels) 30 µm; (insets) 10 µm. (D) XZ and YZ
projections of serial confocal sections. Bars,
10 µm. (E) CHC depletion on cultured primary
mouse myotubes. Immunofluorescent staining
of -actinin (green) and actin (red) in differentiated primary mouse myotubes treated with
control GAPDH siRNA or CHC siRNA. DNA
staining (DAPI blue) identifies differentiated,
multinucleated myotubes. The boxed region in
the merged images is magnified in the insets.
Bars: (main panels) 20 µm; (insets) 10 µm.
(F) Quantification of striated vs. nonstriated
surface in control (siRNA against GAPDH) or
in myotubes treated with siRNA against CHC
(n = 30–60 myotubes, data are presented as
mean ± SEM; **, P < 0.01).

As expected, control myotubes present a striated -actinin
distribution after 6 d of differentiation. This striated pattern is first
visible at the periphery of the myotube and gradually fills the entire
cytoplasm (Quach and Rando, 2006). In CHC-depleted myotubes,
the -actinin striated pattern was strongly disrupted, and instead,
clusters of -actinin were randomly dispersed in the intracellular
space (Fig. 4 C). 3D projections of confocal sections confirmed a
dramatic reduction of the striated pattern between controls and
CHC-depleted myotubes (Fig. 4 D). Upon CHC depletion, a similar phenotype arises in mouse primary myotubes (Fig. 4, E and F)
in which organization of actin filaments is also affected. To determine the role played by clathrin during the early steps of costamere
formation, we performed siRNA depletion experiments on C2C12
myotubes after 4 d of differentiation, before -actinin and actin
could reach a striated organization. In control myotubes, -actinin
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Figure 5. CHC, AP2, and DNM2 but not AP1
or AP3 depletion in cultured mouse myotubes
perturbs -actinin distribution before striations
appear. (A) Differentiated C2C12 myotubes
were treated with siRNA targeting proteins (indicated at the left). Immunofluorescent staining
of -actinin in myotubes treated with control
siRNA against GAPDH or siRNA targeting either CHC, AP1, AP2, AP3, or DNM2. DNA
staining (DAPI blue) identifies differentiated,
multinucleated myotubes. The boxed region
in the merged images is magnified in the insets. Bars: (main panels) 10 µm; (insets) 5 µm.
(B) Quantification of -actinin fluorescence
surface as a function of total myotube surface
in 4-d differentiated myotubes treated with
siRNA against GAPDH, CHC, AP1, AP2, AP3,
or DNM2 (n = 30–50 myotubes, data are presented as mean ± SEM; **, P < 0.01).

AP2 and DNM2 are required for -actinin
scaffold formation

We next tested the effect of AP2 knockdown on -actinin
subcellular localization. AP2 (-subunit) depletion by siRNA
(Fig. S3 C) induced a strong decrease in the amount of CHC
recruited at the PM. More importantly, AP2 knockdown phenocopied the effect of CHC depletion on -actinin distribution
and dramatically increased the intracellular -actinin staining
(Fig. 5). We have also depleted the AP1 (-subunit) and AP3
(-subunit) adaptors responsible for CHC targeting at the Golgi
apparatus and endosomal systems. As expected, AP1 and AP3
were localized at the perinuclear region and in intracellular
structures dispersed throughout the myotube (Fig. S3 A).
siRNA depletion of AP1 and AP3 drastically reduced the intracellular CHC staining without affecting CHC localization at
the PM (unpublished data). Moreover, knockdown of AP1 and
AP3 had no effect on -actinin distribution (Fig. 5), suggesting
that the impact of CHC depletion on -actinin organization is
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not due to perturbations of the secretory pathway or trafficking
between the endo/lysosomal system.
DNM2 is also present at or near the plasma membrane of
differentiating myotubes, where its staining partially overlaps
with that of -actinin (Fig. S4 C). AP2 depletion strongly reduced the amount of DNM2 at the plasma membrane, suggesting that part of the PM staining corresponds to an association
with clathrin lattices (Fig. S4 D). Efficient DNM2 depletion
(Fig. S3 A) induced an increase in the amount of intracellular
-actinin staining (Fig. 5 and Fig. S4 A). Of interest, these
intracellular aggregates observed upon CHC, AP2, and DNM2
depletion also contain actin aggregates (Fig. S4 A).
We performed the quantification of the intracellular
-actinin–positive area for all siRNA constructs (Fig. 5 B). CHC,
AP2, and DNM2 had a strong impact on the intracellular
-actinin area, whereas AP1 and AP3 values were not different
from controls. Altogether, these results confirm that the primary
impact observed upon CHC depletion on -actinin organization
is related to its cytoskeleton scaffolding role at the PM through
a process also involving AP2 and DNM2.
Hip1R depletion stabilizes -actinin and
actin on clathrin-coated structures

Actin has been shown to be present at CCVs (Collins et al.,
2011), and a requirement for actin has been suggested for clathrin

Downloaded from jcb.rupress.org on June 3, 2014

was mainly localized along the PM. In stark contrast, myotubes
that had been depleted of CHC presented a strong increase in the
amount of intracellular -actinin (Fig. 5 A). These results demonstrate that CHC is required for proper -actinin distribution during
early myotube differentiation.
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Figure 6. Hip1R depletion in cultured myotubes stabilizes actin and -actinin on clathrin-coated structures. (A) Immunofluorescent staining of -actinin
(green) and Hip1R (red) in differentiated C2C12 myotubes treated with control siRNA against GAPDH or siRNA targeting Hip1R. DNA staining (DAPI
blue) identifies differentiated, multinucleated myotubes. The boxed region in the merged images is magnified in the insets. Bars: (main panels) 10 µm;
(insets) 5 µm. (B) -Actinin localization in differentiated C2C12 skeletal muscle cells treated with siRNA targeting Hip1R. The left panel displays an image
from the bottom of the myotube and the right panel displays an image from the top of the myotube. The boxed regions in the images are magnified in the
insets 1 and 2. Bars: (main panels) 10 µm; (insets) 5 µm. (C) Immunofluorescent staining of actin and CHC in myotubes treated with control siRNA against
GAPDH or siRNA targeting Hip1R. DNA staining (DAPI blue) identifies differentiated, multinucleated myotubes. The boxed region in the merged images
is magnified in the insets. Bars: (main panels) 10 µm; (insets) 5 µm. (D) Actin localization in differentiated C2C12 skeletal muscle cells treated with siRNA
targeting Hip1R. The left panel displays an image from the bottom of the myotube and the right panel displays an image from the top of the myotube. The
boxed regions in the images are magnified in the insets (1 and 2) and include CHC staining (red). Bars: (main panels) 10 µm; (insets) 5 µm. Arrows in A,
C, and D indicate large peripheral clusters of -actinin or actin and CHC.

plaque formation (Saffarian et al., 2009). Interaction between
actin and clathrin is mediated by Hip1R (huntingtin-interacting
protein 1–related protein) and CLC (Engqvist-Goldstein et al.,
2001, 2004; Chen and Brodsky, 2005; Legendre-Guillemin et al.,
2005; Brodsky, 2012). In myotubes, Hip1R colocalizes with
AP2-positive puncta in differentiated myotubes (Fig. S3 D). We
tested the effect of both CHC and AP2 depletion on Hip1R
(Fig. S3 D) and showed a dramatic reduction of the Hip1R
staining at the PM. These results confirm that CHC and AP2 are
required for recruiting the clathrin-associated actin-binding protein Hip1R to the PM. It has been shown that Hip1R depletion stabilizes the actin filaments on clathrin-coated plaques in HeLa cells
(Engqvist-Goldstein et al., 2004). We decided to test the contribution of Hip1R on the distribution of actin and -actinin in differentiated myotubes. siRNA depletion of Hip1R drastically reduced
Hip1R protein levels (Fig. S3 A). Hip1R-depleted myotubes had
a disorganized actin cytoskeleton and -actinin distribution. The

Hip1R-depleted myotubes accumulated unusual actin structures
near the cell cortex (Fig. 6). These structures, which are very similar to the ones observed by Engqvist-Goldstein et al. (2004) upon
Hip1R depletion in HeLa cells, took a variety of forms, including
tails and rings at the bottom and the top of differentiated myotubes
(Fig. 6 and Fig. S4 B). These results demonstrate that when Hip1R
expression is reduced, actin polymerization at clathrin-coated
structures is no longer properly regulated and results in accumulation of actin and -actinin on clathrin-coated plaques.
CHC is required for sarcomere
maintenance in mature isolated
muscle fibers

We then assessed the function of CHC in mature skeletal muscle fibers. For this purpose, we developed an AAV strategy combined with the use of a short hairpin RNA (shRNA) against
CHC (AAV-shCHC) for ex vivo transduction of isolated fibers
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Figure 7. CHC is required for sarcomere
maintenance in adult fibers. (A) Quantitative
RT-PCR and (B) Western blot analysis of CHC
levels and proteins indicated at the right in
FDB fibers infected with AAV-CTRL or AAVshCHC for 12 d in vitro. (C) Quantification of
Western blot CHC band intensity (n = 3, data
are presented as mean ± SEM; for A and C:
**, P < 0.01). (D–G) Confocal microscopy of
dissociated FDB fibers infected with AAV-CTRL
or AAV-shCHC for 12 d and co-stained with
antibodies against either -actinin and CHC
(D), -actinin and DNM2 (E), or F-actin (phalloidin staining) and caveolin-3 (F and G). All
bars, 10 μm.

Downloaded from jcb.rupress.org on June 3, 2014

from flexor digitorum brevis (FDB) muscle. In AAV-shCHC–
infected fibers, a strong decrease in CHC expression was confirmed, both at the RNA and protein level (Fig. 7, A–C), and
-actinin was no longer correctly localized, with very few
striations noticeable and displaying a diffuse or disorganized
staining pattern (Fig. 7 D). We also tested the effect of CHC
depletion on DNM2 distribution. In control fibers, DNM2 displayed a striated pattern at the surface, with each striation being
centered on the I-band, and in the core of the fiber DNM2 was
mainly present at the PM (Durieux et al., 2010; Cowling et al.,
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2011). In fibers depleted of CHC, the DNM2 signal at the
core of the fiber was greatly reduced at the PM (Fig. 7 E). To
assess the effect of CHC depletion on the integrity of the actin
cytoskeleton we used phalloidin staining. In control fibers, F-actin
displayed a regularly spaced striated distribution. However, CHCdepleted fibers presented a diffuse actin distribution (Fig. 7 F),
and in some fibers detachment of entire sarcomeric bundles
(Fig. 7 G). In addition to its role in costamerogenesis, these data
suggest that CHC is also involved in their preservation in
mature fibers.

Published May 5, 2014

In vivo CHC depletion impairs force and
causes muscle degeneration

In vivo CHC depletion perturbs -actinin,
-actin, and DNM2 distribution

We then sought to analyze the distribution of -actinin, DNM2,
and the costameric actin isoform -actin (Sonnemann et al.,

Downloaded from jcb.rupress.org on June 3, 2014

We used AAV-shCHC in order to induce an in vivo depletion of
CHC in tibialis anterior (TA) muscle. By performing hematoxylin and eosin staining on transverse TA sections (Fig. 8 A), no
histological change was visible in muscles injected with control
AAV or with AAV-shCHC until day 18 post-injection (PI).
However, fibers displaying a rounded shape with a clearly
disorganized intracellular space were noticed at day 21 PI.
Between days 21 and 23 PI some degenerating fibers appeared,
and by day 25 PI the vast majority of the fibers had a rounded
shape with a clear degenerating phenotype. As a general feature
of muscle degeneration, an immune infiltration was visible at
day 21 and was extremely pronounced by days 23 and 25 PI. At
day 25, small myotubes appeared and their presence reached a
peak by day 38 where the majority of the muscle was centrally nucleated, the signature of a muscle undergoing massive regeneration.
Quantitative RT-PCR and Western blot analysis confirmed
that at day 18 PI a strong decrease in CHC had indeed occurred
(Fig. 8, B–D). When we measured CHC RNA and protein levels
at later time points, we noticed that CHC levels increased from
40% back to 55% of control levels at day 21 PI and were back to
control levels by day 23. Surprisingly, at day 25 PI, CHC levels
were higher in the AAV-shCHC–injected muscle compared with
the contralateral control muscle (Fig. 8, B and C). A possible explanation is that the infiltration by macrophages contaminates our
analysis with exogenous clathrin from nontransduced immune
cells. Indeed, at days 21, 23, and 25 PI a strong increase in CD11b
protein levels was evident (Fig. 8 C and Fig. S5, A and B).
Immunofluorescent staining confirmed that CD11b-positive
macrophages had massively infiltrated the CHC-depleted muscle.
In fact, CD11b protein levels correlated perfectly with the sudden
increase in CHC levels. To circumvent the immune infiltration
and to show that a clathrin knockdown had occurred, we performed immunoprecipitation experiments using antibodies
against the muscle-specific -actinin isoform. This assay enabled
us to show that in muscles injected with AAV-shCHC, there was
a strong decrease in the amount of CHC which coimmunoprecipitated with -actinin (Fig. 8 E).
Direct muscle stimulation was performed in order to measure the maximal isometric strength of the TA muscle in CHCdepleted muscles. At day 18 PI, when no morphological
alteration could be observed, CHC depletion induced a 57% decrease in specific maximal force, i.e., absolute maximal force
divided by muscle weight (Fig. 8 F). At day 21 PI, CHC depletion had an even more robust effect; muscle depleted of CHC
displayed a 74% decrease in specific maximal force (Fig. 8 F).
No significant muscle mass loss was observed at both early timepoints (Fig. 8 G). These results show that AAV-shCHC efficiently
knocks down CHC in vivo with dramatic consequences in terms of
muscle fiber homeostasis.

2006) in CHC-depleted skeletal muscle by immunocytochemistry. At 18 d PI, the -actinin labeling was not different from
the control, whereas a clear reduction in sarcolemmal clathrin
was apparent (Fig. 9 A). However, at day 21 and at further
time points (day 23 and day 25), -actinin and -actin both
displayed a diffuse distribution compared with control muscle,
and areas where -actinin was no longer adjacent to the sarcolemma were also visible (Fig. 9, B–D). In addition, in control
fibers DNM2 presented a strong PM staining and a weak intracellular staining. At day 21 and at further time points (day 23
and day 25) the DNM2 intracellular staining was greatly enhanced (Fig. 9, B and D). We also tested the effect of CHC
depletion on the distribution of other costameric proteins such
as dystrophin, -dystroglycan, and caveolin-3 (Fig. S5, B and C).
Even though at days 23 and 25 the muscle presented a severe
dystrophic phenotype, no change in the distribution of these
proteins was noticeable. We therefore conclude that CHC
depletion has a strong effect on the localization of intracellular costameric proteins related to the actin cytoskeleton, including -actin, actin-associated proteins, and DNM2, without
affecting the distribution of dystrophin and PM integral
components such as members of the dystrophin-associated glycoprotein complex.
In vivo CHC depletion induces
disorganization of the contractile
apparatus and detachment between
the sarcolemma and myofibrils

We performed electron microscopy analysis of CHC-depleted
muscle at day 18 PI (without phenotype upon HE analysis) and at
day 25 PI (peak of degeneration). At day 18 PI, focal regions displayed sarcomere abnormalities such as Z-band streaming and disorganization of the contractile apparatus especially in the I-band
region (Fig. 10, A–C). It is of interest that these focal sarcomeric
disorganizations were usually found adjoining the sarcolemma. In
addition, at day 18 PI, occasional detachments of the sarcomeric
apparatus from the sarcolemma were visible (Fig. 10, E–G). Both
these phenotypes were consistent with the phenotypes produced
upon clathrin depletion on isolated fibers. Of note, the T-tubule and
sarcoplasmic reticulum system did not seem affected in the disorganized regions (Fig. 10 D). At day 25 PI, both transverse (Fig. 10,
H–J) and longitudinal sections (Fig. 10, K and L) presented a particularly exacerbated detachment phenotype, with fibers displaying
large areas of the sarcolemma that were no longer associated with
sub-sarcolemmal sarcomeres.

Discussion
In this study, we identify a new role for CHC in costamere formation and maintenance. Our results raise the possibility that
CHC, AP2, and DNM2 contribute to the formation of the costameric scaffold that is necessary for anchoring the actin cytoskeleton by recruitment of actin-binding protein Hip1R and
actin cross-linking protein -actinin early during myotube differentiation. Consequently, depletion of CHC, by perturbing the
actin cytoskeleton and redistributing -actinin, has a strong
effect on the formation and maintenance of the contractile
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Figure 8. CHC depletion using AAV-shCHC in vivo impairs force and causes muscle degeneration. (A) Hematoxylin and eosin staining of AAV-CTRL– or
AAV-shCHC–injected muscle at day 18, 21, 23, 25, and 38 after virus injection. (B) RT-qPCR of CHC mRNA levels at different time points after AAV-CTRL
or shCHC AAV injection (n = 2–9 mice, data are presented as mean ± SD; *, P < 0.05; **, P < 0.01). (C) CHC protein levels at different time points
after AAV-CTRL or shCHC AAV injection. The full time-course of CD11b levels, including the D23 and D25 time points shown here, is shown in Fig. S5 A.
(D) Quantification of Western blot CHC band intensity (n = 4 mice at day 18, data are presented as mean ± SEM; *, P < 0.05; Mann-Whitney U test).
(E) Immunoblot analysis of proteins associated with -actinin or control immunoprecipitates of TA muscle lysates injected with AAV expressing a control
construct or AAV expressing shCHC at 21 d after injection. (F and G) Measures of the specific maximal force (F) and of the muscle weight (G) of isolated
TA muscle injected with AAV expressing a control construct or AAV expressing the shCHC construct (n = 3–5 mice) at either 18 or 21 d after injection.
Data are presented as means ± SEM; for F: *, P < 0.05; **, P < 0.01.
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Figure 9. -Actinin, -actin, and DNM2 distribution is perturbed upon in vivo CHC depletion. (A–D) Confocal microscopy on transverse sections of skeletal
muscle processed for double-immunofluorescent labeling using antibodies against (A) CHC (red) and -actinin (green) at day 18 PI; (B) -actinin (green)
and DNM2 (red); (C) -actinin (green) and DAPI (blue); (D) and -actin (green) and DNM2 (red) at day 21 PI. The boxed region in the merged images
is magnified in the insets. Arrowheads point at regions of the fiber where the -actinin staining is no longer associated with the sarcolemma. Bars: (main
panels) 30 µm; (insets) 20 µm.

apparatus. The possibility that we are observing defective
-actinin trafficking inside the cell toward the PM is improbable
because -actinin is not a membrane-associated protein, does
not colocalize with clathrin in intracellular compartments, and
because AP1 and AP3 knockdown does not induce an -actinin
redistribution phenotype. In fact, our results clearly point toward a defect in the attachment of -actinin to the cytoplasmic side of the PM and raise the possibility that clathrin is
involved in actin scaffolding, thereby performing a task similar
to what has been described for bacterial uptake, adherens
junctions, and immune synapses (Bonazzi et al., 2011, 2012;
Calabia-Linares et al., 2011). In addition, our results demonstrate a predominant role for AP2 in CHC targeting to the PM of
differentiated myotubes.
The assembly of clathrin in plaques has been previously
observed in several cell types, including muscle cells, but their
physiological importance has proven controversial (De Deyne
et al., 1998; Pumplin, 1989; Pumplin and Bloch, 1990; Akisaka
et al., 2003; Bellve et al., 2006; Saffarian et al., 2009) and their
functional role is still not clear. They were thought to represent
artifacts of cell adhesion of cultured cells. However, large clathrin lattices have also been observed in non-adherent floating

cultured adipocytes (Bellve et al., 2006) and we observe them
on non-adherent regions such as the top or the sides of myotubes (Fig. 2 D and Fig. S4 B). Because one putative role for
clathrin-coated membrane domains is to maintain the stable attachment to the substrate, we suggest that clathrin plays the
same role at the costamere, which is the muscle-specific adhesion site.
These large clathrin-coated plaques are also endocytically
active, and invaginated pits are frequently observed at their
edges. The implication of both CHC and DNM2 in focal adhesion turnover has previously been reported (Ezratty et al., 2005,
2009). Therefore, one may hypothesize that this protein complex responsible for formation and maintenance of the costameres is also involved in the turnover of these structures by
endocytosis. In addition, we cannot exclude that the defects we
are observing both in vitro and in vivo are at least partially due
to defective endocytosis of costamere components. However,
because (a) plaques in myotubes contain much more polymerized clathrin than would be required to form a single vesicle,
(b) adhesion inhibits clathrin-mediated endocytosis (Batchelder
and Yarar, 2010), and (c) endocytosis is reduced during differentiation (Kaisto et al., 1999), the defects we are observing

Clathrin heavy chain is required for sarcomere organization • Vassilopoulos et al.

387

Published May 5, 2014

Downloaded from jcb.rupress.org on June 3, 2014
Figure 10. Sarcomeric disorganization and detachment between sarcolemma and myofibrils upon in vivo CHC depletion. Transmission electron microscopy of longitudinal (A–D, K–L) and transverse (E–J) muscle sections from mice injected with AAV-shCHC constructs at day 18 (A–G) and day 25 PI (H–L).
In A–D, the sarcomeric apparatus is disorganized in focal regions adjoining the sarcolemma (within the dotted lines in A) and presents streaming and
disassembly of the Z-line. C and D are insets of the respective boxed regions in B. In E–G, small detachments between the sarcolemma and the contractile
apparatus are visible at day 18 PI. At day 25 PI, large detachments are seen in both transverse (H–J) and longitudinal orientation (K–L). I is an inset of the
boxed region in H; J is an inset of the boxed region in I; L is an inset of the boxed region in K. Arrows in E, H, and L indicate detachments.
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muscle (Cowling et al., 2011), and we show that DNM2 is
required for proper -actinin organization. Recently, a CNMrelated DNM2 mutation was associated with an accumulation
of electron-dense material located between disorganized myofibrils as well as DNM2 and CHC mislocalization within the
atrophied myofiber (Kierdaszuk et al., 2013). In addition, overexpression of DNM2 mutants in mouse skeletal muscle leads to
-actinin structural defects with prominent misalignment of the
Z-line in vivo, which may explain at least in part the reduced
specific maximal force observed in these mice (Cowling et al.,
2011). All these data associated with the undeniable role of
DNM2 in regulation of actin cytoskeleton dynamics and focal
adhesion maintenance (Ezratty et al., 2005, 2009) highlight
a new putative pathomechanism of DNM2-related CNM that
merits further investigation.
Overall, our experiments clearly demonstrate the involvement of the CHC, the AP2 adaptor protein, Hip1R, and DNM2
in the formation of structures that, through association with
-actinin and actin filaments, allow the organization of the contractile apparatus in close association with the sarcolemma. The
present study sheds light on a long-standing question, namely,
the role of clathrin in skeletal muscle sarcomeric structure organization. Altogether, our results highlight an unconventional,
novel role for clathrin in striated muscle that may be relevant to
muscle physiology and whose dysfunction could be associated
with the physiopathology of CNM linked to DNM2 mutations.
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are probably not mainly due to endocytosis defects but could
relate to the scaffolding role of CHC and DNM2 for the actin
cytoskeleton (Schafer et al., 2002).
Our experiments show that these large clathrin-coated
structures are intimately associated with the actin cytoskeleton
and actin-binding proteins such as -actinin. Because vinculin
and talin were not detected in our coimmunoprecipitation experiments and because vinculin did not localize on clathrincoated plaques (unpublished data), we believe that the coated
domain corresponds to a different entity from classical focal
adhesion contacts. The detection of clathrin plaques in situ in
adult skeletal muscle is of great interest but remains technically
challenging at the moment. It is of interest that costameres have
been recurrently described as sub-sarcolemmal dense plaques
(Chiesi et al., 1981; Pardo et al., 1983a,b; Shear and Bloch,
1985), and therefore it is tempting to speculate that part of the
density which characterizes these structures could be attributed
to clathrin plaques.
Early during in vivo clathrin depletion appear signs which
point toward defects in costamere function. The first phenotype
attributed to clathrin depletion is the presence of small detachments between the sarcolemma and the underlying myofibrils.
CHC knockdown induces sarcomeric disorganization with
streaming of the Z-line, which leads to a drastic and rapid muscle degeneration. Our in vivo experiments confirm the results
obtained on differentiated myotubes and again point toward a
role for CHC in the formation of stable plasma membrane compartments, which contributes to the attachment of sarcomeric
lattices. Our results also point toward differences between three
different costamere complexes. The first is centered on the DGC
complex, dystrophin, ankyrins, and plectin (Ayalon et al., 2008;
Randazzo et al., 2013), the second is centered on integrins,
vinculin, -actinin, and talin (Pardo et al., 1983a,b; Belkin
et al., 1986), and the third is centered on integrins, -actinin,
and clathrin plaques (this paper); all three contain branched
actin filaments. Also, the strong maximal force-loss seen in the
clathrin-depleted muscle before any significant histological sign
testifies to the vital role played by clathrin. The fact that more
than 40% of the direct maximal force is lost before any change
in total muscle mass or before the appearance of histological
changes at the photon microscopy level could be attributed to
the loss of both longitudinal and lateral force transmission in
these myofibers. This force loss can be a direct consequence
of both the large areas where disorganization of sarcomeres is
evident and an uncoupling between the sarcolemma and the underlying contractile apparatus. Although the contribution of a
trafficking dysfunction cannot be excluded, we believe that
clathrin plays a structural role at the plasma membrane and that
first appear signs related to this structural function.
Autosomal-dominant CNM is a rare neuromuscular disorder due to mutations in the DNM2 gene (Bitoun et al., 2005).
The results reported here and previous data suggest that impairment of CHC and DNM2 function in the formation and maintenance of the contractile apparatus via costamere organization
may be relevant in CNM pathophysiology. Similarly to clathrin,
DNM2 is mainly localized at the PM and the Z-line, where it
colocalizes with -actinin in both mouse and human skeletal

Materials and methods
Antibodies
Anti-CHC mouse monoclonals X22 and TD.1, rabbit polyclonal against
clathrin light chains (anti-consensus), and mouse monoclonal AP6 (against
-subunit of AP2) used in this study were produced by Dr. Brodsky’s laboratory. The rabbit polyclonal antibody against CHC is from Abcam. For CHC
detection in immunohistochemistry, immunocytochemistry, and electron microscopy we used the mouse monoclonal X22 antibody. The rabbit polyclonal was used for double-immunofluorescent labeling. Both X22 and the
rabbit polyclonal anti-CHC completely colocalize. For Western blot experiments, both mouse monoclonal TD.1 and rabbit polyclonal (Abcam) antibodies were used. Other commercial sources of antibodies were as follows:
mouse monoclonals against -actinin 2, smooth-muscle actin, -actin, vinculin, and talin (Sigma-Aldrich); mouse monoclonal SA4 against AP3 (-subunit
DSHB); rabbit polyclonal against AP1 (-subunit); rabbit polyclonal antiDNM2, rabbit polyclonal anti-integrin 5, rabbit polyclonal anti-GAPDH,
and rabbit polyclonal anti-CD11b (Abcam); goat polyclonal anti-caveolin3
(Santa Cruz Biotechnology, Inc.); rabbit polyclonal against dystrophin and
mouse monoclonal against -dystroglycan (Novocastra); and rabbit polyclonal against Hip1R (EMD Millipore). Secondary antibodies for immunofluorescence were from Life Technologies (Alexa Fluor 488, 568, and 633
conjugates). Secondary antibodies coupled to horseradish peroxidase
were from Jackson ImmunoResearch Laboratories, Inc.
Muscle tissue lysate
Lysates of whole tissue were prepared from freshly dissected mouse skeletal
muscle. Tissue was homogenized by dounce in lysis buffer (1 mg/3 ml 50 mM
Tris-HCl, pH 7.5, 0.15 M NaCl, 1 mM EDTA, 1% NP-40, and 1 protease
inhibitor cocktail tablet [1:10 ml buffer; Roche]). Homogenate was centrifuged for 10 min at 14,000 g, and the pellet discarded to obtain a postnuclear supernatant. Protein concentration of the lysate was determined by
Bradford assay (Bio-Rad Laboratories).
Immunoblot analysis
Protein samples were separated by electrophoresis (4–12% bis-acrylamide
gel; Life Technologies), then electrophoretically transferred to 0.45-µm
nitrocellulose membranes (Life Technologies) and labeled with primary
antibodies and secondary antibodies coupled to horseradish peroxidase.
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The presence of proteins in samples was detected using Western Lightning
chemiluminescence reagent (GE Healthcare). Quantification was performed using Quantity One software (Bio-Rad Laboratories).
Subcellular fractionation
3T3 fibroblasts, C2C12 myoblasts, and differentiated C2C12 myotubes
were homogenized in HES buffer at pH 7.4 (20 mM Hepes, 1 mM EDTA,
and 225 mM sucrose) by passing 10× through a 27-gauge needle. Homogenates were centrifuged for 20 min at 19,000 g. The resulting pellets were
resuspended in HES buffer, layered on top of a 1.12-M sucrose cushion
and centrifuged at 101,000 g for 60 min at 4°C. The PM fraction was collected from the interface of the two solutions. Centrifugation of the initial
supernatant (212,000 g) for 60 min at 4°C allowed separation of the intra
cellular membrane fraction (pellet) and cytosol (supernatant).

Dissociated fiber cultures
Myofibers were isolated from the dissected FDB muscle of 6-wk-old mice by
digestion with collagenase 1a (Worthington Biochemical Corporation) and
mechanical dissociation. Isolated fibers were cultured (37°C, 5% CO2) in
DMEM with high glucose, 1% horse serum (Gibco), and penicillin/streptomycin on coverslips coated with Matrigel (BD). Myofibers were transduced
with 70 µl of AAV vector (7 × 1010 viral genomes/well) for 12 d.
Mouse myoblast cultures
Primary skeletal muscle cells and C2C12 cells were maintained in tissue
culture dishes coated with rat tail collagen in basal medium with 20% fetal
bovine serum (FBS), 50 U/ml penicillin, and 50 mg/ml streptomycin
(growth medium). Differentiation was induced when cells were 80% confluent by culturing in differentiation medium (basal medium with 2% horse
serum). For siRNA treatment, cells (differentiated for either 4 or 6 d) were
transfected using 10 nM siRNA and transfection reagent (jetPRIME; PolyPlus Transfection) according to the manufacturer’s instructions. Targeting
and GAPDH-specific control siRNAs were synthesized by Eurogentec. For
CHC, sequences targeted were similar to those used in Ezratty et al. (2009):
5-AACAUUGGCUUCAGUACCUUG-3 for CHC-1, 5-AAUGGAUCUCUUUGAAUACGG-3 for CHC-2, and 5-GAGCAUGUGCACGCUGGCCAGCU-3 for the -subunit of AP2. The GAPDH siRNA sequence was
5-AAAGUUGUCAUGGAUGACC-3 and was used as a negative control
in all siRNA experiments. The sequence of the siRNA specific for the -subunit
of the AP1 complex (-adaptin) was 5-AGCUAUGAAUGAUAUAUUA-3,
which is similar to the sequence used in Dugast et al. (2005) and Braun
et al. (2007). The sequence of the siRNA specific for the -subunit of the
AP3 complex (-adaptin) was 5-CAUCAAGAUCAUCAAGCUG-3, which
is similar to the sequence used in Braun et al. (2007). The sequence of the
siRNA specific for DNM2 was 5-ACCUACAUCAGGGAGCGAGAA-3.
The sequence of the siRNA specific for Hip1R was 5-AACUCCUGCACAGACCUGAUG-3, which is similar to the sequence used in EngqvistGoldstein et al. (2004). For CHC depletion, cells were transfected twice for
48 h. For all other siRNA constructs, cells were transfected once for 48–72 h.
Immunofluorescence microscopy
Adult mouse skeletal muscle was embedded in Tissue-Tek OCT compound
(Miles, Inc.), frozen, and stored at 80°C. Cryosections (10-µm thick)
were fixed (15 min, 4% paraformaldehyde in PBS or 10 min, 95% ethanol
[Fig. 1 D] at room temperature [RT]), permeabilized (5 min, 0.5% Triton
X-100 in PBS at RT), and blocked (30 min, PBS with 0.1% Triton X-100, 5%
bovine serum albumin [BSA]). Sections were incubated with primary antibodies (overnight, 4°C, in PBS with 0.1% Triton X-100 and 5% BSA) and
washed in PBS with 0.1% Triton X-100. Sections were then incubated with
secondary antibodies (60 min at RT), washed in PBS with 0.1% Triton
X-100, and mounted with anti-fading solution (DABCO) containing
300 nM DAPI. For double labeling, the two primary antibodies (from different
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Image analysis
Striated surface measurement. The -actinin striated surface per myotube

was quantified by manually drawing a region of interest in ImageJ around
the striated or total cell surface in a single Z-stack from the middle of the
cell. The striated surface was obtained by performing the ratio between
striated and total myotube surface.
-Actinin aggregate size analysis. The “Analyze Particles” ImageJ plugin (version 1.46) was used to count intracellular particles on binary confocal images of C2C12 myotubes in a single Z-stack from the middle of the
cell and to automatically measure the number and area of these particles.
shRNA constructs
The siRNA against CHC (CHC-1) used for in vitro transfection experiments
was synthesized to be directly cloned in pSUPER under the control of the
H1 promoter. ShRNA consisted of a 21-nt sense sequence followed by a
9-nt loop (TTCAAGAGA), a 19-nt reverse sequence, and an RNA pol III
terminator (TTTTT). The H1 cassette was then introduced into an AAV1based vector between the two ITRs using the blunted SpeI and SalI sites on
pSUPER-shRNA plasmid and the XbaI site on the pSMD2 AAV2 vector
backbones, which were type 1 pseudotyped (Généthon).
Virus production and titration
AAV2/1 pseudotyped vectors were prepared by transfection in 293 cells as
described previously (Rivière et al., 2006) using the pSMD2-shRNA plasmid,
the pXX6 plasmid (Généthon) coding for the adenoviral sequences essential
for AAV production, and the pRepCAp plasmid (Généthon) coding for AAV1
capsid. Vector particles were purified on iodixanol gradients and concentrated on Amicon Ultra-15 100K columns (EMD Millipore). The final viral preparations were kept in PBS solution at 80°C. The particle titer (number of viral
genomes) was determined by quantitative PCR. Titers for AAV shCHC were
4 × 1012 vector genomes (vg)/ml.

In vivo gene transfer
Experiments were performed on adult 8-wk-old C57/BL6 mice. Anesthesia
was achieved with a mix of 100 mg/kg ketamine and 10 mg/kg xylasine
or using isoflurane. Two intramuscular injections (40 µl/TA), 24 h apart of
AAV-shCHC, was performed in TA of the right hindlimb; the contralateral
muscles were injected using the same procedure with control AAV vector
(AAV-CTRL), which expresses the muSEAP protein (murine-secreted embryonic alkaline phosphatase). Mice were sacrificed at different intervals after
the injection.

Downloaded from jcb.rupress.org on June 3, 2014

Immunoprecipitation
For 3T3 and C2C12 subcellular fractions (PM and cytosol), 250 µl of each
fraction was diluted to half using lysis buffer (50 mM Tris-HCl, pH 7.5,
0.15 M NaCl, 1 mM EDTA, 1% NP-40, and 1 protease inhibitor cocktail
tablet [1:10 ml buffer; Roche]). Mouse skeletal muscle tissue lysate (postnuclear supernatant) was diluted to 3 mg/ml in lysis buffer, precleared with
30 µl washed protein G–Sepharose (PGS 4 fast flow; GE Healthcare)
per 400 µl of diluted lysate, and incubated with 20 µg of specific antibody overnight (4°C). Then 30 µl washed PGS was added and incubated
for 1 h at 4°C. Pelleted PGS was taken up in sample buffer and subjected
to electrophoresis and immunoblotting. For all immunoprecipitation experiments, HRP-conjugated rabbit and mouse IgG TrueBlot secondary antibodies (eBioscience) were used.

species) or the two secondary antibodies were added simultaneously at the
appropriate step. Secondary antibodies were labeled with either Alexa
Fluor 488 or Alexa Fluor 568.
For myofibers isolated from mouse muscle, immunolabeling was performed directly in the 24-well culture plate. Cells were fixed (15 min, 4%
paraformaldehyde in PBS at RT), permeabilized (10 min in PBS with 0.5%
Triton X-100), and immunolabeled using the same procedure described for
mouse muscle sections.
For mouse cells grown on coverslips, cells were washed in warm
PBS, fixed in paraformaldehyde (4% in PBS, 15 min), then washed in PBS,
permeabilized (10 min, 0.5% Triton X-100 in PBS) and blocked in blocking
solution (5% BSA in PBS with 0.1% Triton X-100, 30 min). Antibody labeling was performed by addition of 200 µl blocking solution with primary or
secondary antibodies (1–5 µg/ml) and washing with PBS with 0.1% Triton
X-100. Samples were mounted in Vectashield containing DAPI (Vector
Laboratories).
Muscle sections, mouse cells, and myofibers from mouse muscle
were analyzed by confocal laser scanning microscopy using an inverted
operating system (SP2; Leica) equipped with HCX Plan-Apo CS 40×/1.20
NA and 63×/1.40 NA oil immersion objective lenses. Images presented
in Figs. 1 A, 5, 6, S3, and S4 were acquired using an upright confocal
laser scanning microscope (FV-1000; Olympus) equipped with a UPlanSApo 60×/1.35 NA oil immersion objective lens. DAPI, Alexa Fluor 488,
and Alexa Fluor 568 fluorescence was sequentially excited using lasers
with wavelengths of 405 for DAPI, 488 (Leica) or 473 (Olympus) for
Alexa Fluor 488, and 543 nm for Alexa Fluor 568. Z-series from the top
to the bottom of fibers were sequentially collected for each channel with
a step of 0.9–1 µm between each frame. Imaging was performed at
room temperature using Type F immersion oil (Leica). Images (1024 ×
1024 pixels) were saved as TIFF files in Olympus FV-1000 software and
Leica confocal software, and input levels were adjusted in Adobe Photoshop. Image quantification was performed using ImageJ (National Institutes of Health).
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Gene expression analysis
Total RNA was prepared from 400-µm cryostat sections of TA using the
Nucleospin RNAII kit (Macherey-Nagel). Complementary DNA generated
with the Superscript II Plus reverse transcription kit (Life Technologies) was
analyzed by real-time qPCR performed on an Opticon2 system (Bio-Rad
Laboratories) using iTaq SyberGreen Supermix with ROX (Bio-Rad Laboratories). In all samples, we quantified transcript of the PO gene encoding mouse acidic ribosomal phosphoprotein ubiquitously expressed as
endogenous RNA control, and each sample was normalized on the basis
of its PO content. Primers used for CHC: forward exon 6, 5-GAGTCAAC
AGAAAGGGACA-3; reverse exon 7, 5-CATTCTCAGAGCCAAGTCAG-3.
Primers used for PO: forward, 5-CTCCAAGCAGATGCAGCAGA-3; reverse, 5-ATAGCCTTGCGCATCATGGT-3.

Dual-Mode Lever; Aurora Scientific). Muscles were directly stimulated by a
bipolar silver electrode using a supramaximal (80 V) square wave pulse of
0.1-ms duration. Absolute maximal force (P0) was measured during isometric contractions in response to electrical stimulation (frequency of 25–150
Hz; train of stimulation of 500 ms). All isometric contraction measurements
were made at optimal muscle length (L0) at which P0 was obtained. TA
muscles were weighted and specific maximal force (sP0) was calculated by
dividing P0 by muscle weight.

Histomorphological and ultrastructural analyses
Samples were frozen in liquid nitrogen–cooled isopentane. Transverse sections of TA muscle (8-µm thick) were stained with H&E by standard methods. Light microscopy was performed using an upright microscope (DMR;
Leica) and a 40×/NA 0.85 HCX Plan Apo objective (Leica). Images were
captured using a monochrome camera (DS-Ri1; Nikon) and NIS-Elements
BR software (Nikon). For all imaging, exposure settings were identical between compared samples and viewed at room temperature.
For morphological electron microscopy, muscles were fixed by intraaortic perfusion with 2% paraformaldehyde and 2% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.4). TA samples were post-fixed with 2% OsO4, in
0.1 M phosphate buffer (pH 7.4) for 1 h, then dehydrated in a graded series of acetone including a 1% uranyl acetate staining step in 70% acetone
and finally embedded in epon resin. For pre-embedding immunogold clathrin labeling, mice were fixed with 2% paraformaldehyde and TA longitudinal 100-µm-thick sections were cut with a vibratome. Then a standard
free-floating immunocytochemical procedure was followed, using 0.1 M
saline phosphate buffer as diluent and rinsing liquids. After pre-incubation
in 5% normal goat serum, 5% BSA, sections were incubated overnight at
4°C in 1:500 anti-clathrin antibody. A further 4-h incubation in ultra-small
gold conjugate of goat anti–rabbit IgG (1:20; Aurion) was followed by extensive washings, 10 min post-fixation in 2% glutaraldehyde, and 0.70-nm
gold beads were then silver enhanced (HQ silver; Nanoprobes). After 15 min
post-fixation in 1% OsO4, sections were dehydrated in graded acetone
and embedded in epon resin.
Thin (70 nm) sections were stained with uranyl acetate and lead citrate, and in some cases (Fig. 1 F) a 1% tannic acid (1 min) staining step
preceded uranyl staining. Observations were made on an electron microscope (model CM120; Philips) and images were recorded with a Morada
digital camera (Olympus).

Online supplemental material
Fig. S1 shows ultrastructural analysis of tannic acid–stained muscle sections, anti-CHC–labeled muscle sections, and ultrastructural localization of
clathrin in clathrin-coated pits and plaques of unroofed mouse primary
myotubes. Fig. S2 displays additional images of -actinin localization and
localization of 5-integrin in clathrin plaques of mouse primary myotubes.
Fig. S3 shows efficiency of siRNA-mediated AP1, AP2, AP3, DNM2, and
Hip1R depletion, the effect of siRNA-mediated AP2 depletion on CHC distribution, and localization of Hip1R in control and CHC- or AP2-depleted
myotubes. Fig. S4 compares the effect of siRNA-mediated depletion of
CHC, AP1, AP2, Hip1R, and DNM2 on actin distribution, and characterizes localization of DNM2 in control or CHC- and AP2-depleted myotubes.
Fig. S5 shows that in vivo CHC depletion induces a strong inflammatory
response but has no effect of -dystroglycan and dystrophin distribution.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.201309096/DC1. Additional data are available in the
JCB DataViewer at http://dx.doi.org/10.1083/jcb.201309096.dv.

Contractile properties
The isometric contractile properties of TA muscles were studied in situ on
mice anesthetized with 60 mg/kg pentobarbital. The distal tendon of
the TA muscle was attached to a lever arm of a servomotor system (305B
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Electron microscopy of unroofed myotubes
Adherent PM from myotubes cultured as described above were prepared
for rapid-freeze, deep-etch electron microscopy as described previously
(Heuser, 2000). In brief, cells grown on small oriented pieces of glass
coverslip were disrupted by sonication, fixed in paraformaldehyde, and
labeled with anti-clathrin (X22), anti–-actinin, or anti-5 integrin and then
18-nm gold-conjugated anti–mouse or anti–rabbit antibody. Each waterwashed coverslip is mounted on a 3 × 3-mm slab of aldehyde-fixed and
water-washed rabbit lung (0.8-mm thick) that serves as a cushion for the
next step. Then it is quick-frozen by abrupt impact against an ultrapure
copper block cooled to 4 degrees above absolute zero. The coverslip is
stored in liquid nitrogen until mounting in a vacuum evaporator (model
301; Balzers). In this device, it is next freeze-dried by warming it to 80°C
for 15 min, and is then rotary-replicated with a thin (2 nm) film of platinum evaporated over 5–10 s from an electron beam gun mounted 15–20
degrees above the horizontal, all while the coverslip is rotated at 5 Hz.
This “replica” of the coverslip and the cells remaining attached to it is supported by evaporating 10 nm of pure carbon onto it, using a standard
carbon-arc supply mounted 10 degrees off the vertical. The resultant platinum replica is floated off the glass by angled immersion into full-strength
(47%) hydrofluoric acid, washed several times by floatation on distilled
water, and picked up on 75 mesh formvar-coated EM grids. The grid is
mounted in a eucentric side-entry goniometer stage of a transmission electron
microscope (model 1400; JEOL USA, Inc.) equipped with a high-resolution 4K
AMT digital camera. Images were processed in Adobe Photoshop to adjust
brightness and contrast.

Statistics and institutional guideline compliance
Statistical analysis was performed using Student’s t test except as otherwise
stated. All animal studies were performed in compliance with the French
government guidelines.
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